Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 183
B Workshop Participants WORKSHOP ON BLOOD BANK OPERATIONS July 23-24, 1994 James B. AuBuchon, M.D. Medical Director Department of Pathology Dartmouth-Hitchcock Medical Center Jay Epstein, M.D. Center for Biologics Evaluation and Research Food and Drug Administration William Andrew Heaton, M.D. Irwin Memorial Blood Center Paul Holland, M.D. Director Sacramento Medical Foundation P. Ann Hoppe Assistant to the Director Office of Blood Research and Review Food and Drug Administration Claude Lenfant, M.D. Director National Heart, Lung and Blood Institute James MacPherson Executive Director Council of Community Blood Centers Herb Perkins Irwin Memorial Blood Center James Reilly Executive Director American Blood Resources Association Jenni Lee Robins Director, Total Quality Management New York Blood Center George B. Schreiber, D.Sc. Westat, Inc. Ernest R. Simon, M.D. Executive Vice President Scientific, Medical and Technical Affairs Blood Systems, Inc. Edwin A. Steane, Ph.D. Principal Officer American Red Cross Blood Services Charles Wallas, M.D. Director, Blood Bank Vanderbilt University Medical Center 183
OCR for page 184
184 BLOOD AND BLOOD PRODUCTS: SAFETY AND RISK WORKSHOP ON RISK AND REGULATION January 23-24, 1995 Lew Barker Efficacy Trials Branch Vaccine and Prevention Research Program Division of AIDS, NIAID, NIH Celso Bianco, M.D. Vice President, Medical Affairs New York Blood Center Penny Chan, Ph.D. Commission of Inquiry Blood Systems in Canada Toronto, Ontario Harry W. Chen HemaSure Inc. Marlborough, MA Eileen Church Communications Manager American Association of Blood Banks Marcia Crosse Program Evaluation and Methodology Division U.S. General Accounting Office Jacqueline D'Alessio, Ph.D. U.S. General Accounting Office Leonard I. Friedman American Red Cross Holland Lab Elizabeth Goss Fox, Bennett & Turner Washington, DC Harold Kaplan, M.D. University of Texas Southwestern Medical Center Kurt R. Kroemer U.S. General Accounting Office Jan Lane American Red Cross Karen Shoos Lipton CEO American Association of Blood Banks Jane Mackey, MBA Topeka Blood Bank, Inc. James MacPherson Executive Director Council of Community Blood Centers John McCray HemaSure Inc. Marlborough, MA Brian McDonough American Red Cross Arlington, VA Charles Mosher Blood Centers of America, Inc. East Greenwich, RI Jean Otter Director of Regulatory Affairs American Association of Blood Banks Mary K. Pendergast Deputy Commissioner and Senior Advisor to the Commissioner Food and Drug Administration Barbara Peoples American Red Cross Holland Lab
OCR for page 185
APPENDIX B Mark Philip IMMUNO US, Inc. Rochester, MI Beatrice Pierce National Hemophilia Foundation Rancho Santa Fe, CA William H. Portman The Institute for Transfusion Medicine Pittsburgh, PA James Reilly Executive Director American Blood Resources Association Miriam Sparrow, Esq. New York Blood Center, Inc. Edwin Steane, Ph.D. ICCBBA Eugene Timm IMMUNO US, Inc. Rochester, MI Peter Tomasulo, M.D. TM Consulting, Inc. McLean, VA Lee Ann Weitekamp The Blood Center of Southeastern Wisconsin Milwaukee, WI WORKSHOP ON MANAGING THREATS TO TlIE BLOOD SUPPLY September 21-22, 1995 Lew Barker Efficacy Trials Branch Vaccine and Prevention Research Program Division of AIDS, NIAID, NIH Patricia Bezjak Chief Operating Officer Metropolitan Washington Blood Banks Celso Bianco, M.D. Vice President, Medical Affairs New York Blood Center Eileen Church Communications Manager American Association of Blood Banks Brian P. Conway, Esq. Bayer Corporation 185 Richard J. Davey, M.D. Chief Medical Officer American Red Cross Rob Dickstein Director, Regulatory Affairs Pall Corporation Sandra Ellisor Ortho Diagnostic Systems, Inc. Susan Frantz-Bohn Division of Congressional and Public Affairs Center for Biologics Research and Evaluation Food and Drug Administration Steve Friedman Dechert, Price, & Rhoads
OCR for page 186
186 Eric Goosby Office of HIV/AIDS Policy Public Health Service Elizabeth Goss Fox, Bennett & Turner Washington, DC William J. Hammes Associate Counsel Bayer Corporation Harriet Newman, (MT) ASCP Donor Advocate Virginia Blood Services Nancy Newman Knapp, Petersen & Clark Jean Otter Director of Regulatoy Affairs American Association of Blood Banks Stephen Redhead Congressional Research Service Library of Congress James Reilly Executive Director American Blood Resources Association BLOOD AND BLOOD PRODUCTS: SAFER AND RISK Paul Schmidt, M.D. Head, Transfusion Medicine Transfusion Medicine Academic Center Florida Blood Services Toby Simon, M.D. President and CEO Blood Systems, Inc. Harold C. Sox, Jr., M.D. Chairman, Department of Medicine Dartmouth-Hitchcock Medical Center Miriam Sparrow, Esq. New York Blood Center, Inc. Jane Starkey Deputy Director Council of Community Blood Centers Ron Welborn Community Bioresources, Inc. Edward Wolf Senior Associate General Council American Red Cross Sam Wortham Group Vice President Pall Corporation
Representative terms from entire chapter: